Our hypothesis is that the defect in Tregs cells seen in autoimmunity and allergic asthma is not due to a deficiency in the number of Tregs, but rather due to a defect in Treg IL-2R signaling that leads to defective second messenger activity leading to a loss of inhibition of IL-2R desensitization. Here, IL2RA is linked to allergic asthma.